Default company panoramic image

TVAX Biomedical, Inc.

TVAX Immunotherapy is a new approach to the treatment of cancer offering the promise of improved clinical outcomes and reduced side effects.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Lenexa, KS, USA
  • Currency USD
  • Founded November 2004
  • Employees 7
  • Website

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.